The year-end FDA registration and listing cycle can create avoidable pressure when establishment and product listing information needs to be reviewed or updated. Join LexisNexis Life Sciences Solutions...
Your EUDAMED readiness checklist for actor, certificate, product, and UDI data The first four EUDAMED modules became mandatory on May 28, 2026, making EUDAMED an immediate operational requirement for...
Opus Regulatory — Washington, DC | October 20 We'll be at Opus Regulatory's Global Labeling and Regulatory Symposium in Washington, DC. Come find our team to discuss how LexisNexis supports...
Regulatory Affairs Professionals Society — Charlotte, North Carolina | September 15–17 Meet us at RAPS Convergence 2026 in Charlotte — the flagship event for regulatory affairs professionals...
Informa Connect — Berlin, Germany | June 15–18 Find us at the MedTech Summit in Berlin, where regulatory affairs professionals and industry leaders tackle MDR/IVDR compliance and market access...
The 18 July 2025 deadline for Health Canada's mandatory XML Product Monograph (PM) submissions has come and gone — but what has the transition revealed about industry readiness, process challenges, and regulator expectations?
Join us for a post-deadline debrief where regulatory experts share key insights from the initial wave of XML PM submissions. We will explore common hurdles companies faced, lessons learned from successful implementations, and what’s next for those still catching up or preparing for future updates. Whether you submitted on time or are navigating late compliance, this session will provide valuable takeaways to strengthen your regulatory operations moving forward.
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
Contact us